Renato Delascio Lopes
#123,723
Most Influential Person Now
Researcher
Renato Delascio Lopes's AcademicInfluence.com Rankings
Renato Delascio Lopescomputer-science Degrees
Computer Science
#5096
World Rank
#5383
Historical Rank
Computational Linguistics
#628
World Rank
#640
Historical Rank
Machine Learning
#1219
World Rank
#1239
Historical Rank
Artificial Intelligence
#1452
World Rank
#1481
Historical Rank
Download Badge
Computer Science
Why Is Renato Delascio Lopes Influential?
(Suggest an Edit or Addition)Renato Delascio Lopes's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Apixaban versus warfarin in patients with atrial fibrillation. (2011) (6217)
- Initial Invasive or Conservative Strategy for Stable Coronary Disease. (2020) (1071)
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (2018) (993)
- Apixaban with antiplatelet therapy after acute coronary syndrome. (2011) (872)
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. (2020) (853)
- Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 (2020) (834)
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure. (2020) (736)
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation (2019) (698)
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. (2012) (531)
- Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. (2010) (457)
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. (2020) (424)
- The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study (2016) (359)
- The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation (2016) (331)
- Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. (2014) (326)
- Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial (2014) (312)
- Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial (2021) (291)
- Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized, Controlled Trials (2009) (286)
- Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. (2009) (276)
- Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. (2022) (274)
- Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial (2021) (271)
- Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Pathophysiology, Management, and Future Directions (2013) (265)
- Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial (2012) (264)
- Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial (2020) (254)
- Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation). (2014) (252)
- Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. (2021) (251)
- Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. (2009) (228)
- Rationale and design of the Apixaban for the Reduction of Thrombo‐Embolism in Patients With Device‐Detected Sub‐Clinical Atrial Fibrillation (ARTESiA) trial (2017) (224)
- Guidance for the treatment of deep vein thrombosis and pulmonary embolism (2016) (223)
- Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation (2013) (205)
- Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (2014) (205)
- N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). (2013) (196)
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. (2021) (196)
- Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial. (2016) (195)
- Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (2012) (195)
- The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial. (2016) (191)
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. (2021) (182)
- Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial. (2014) (179)
- Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV (2014) (174)
- Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (2015) (166)
- Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. (2013) (162)
- Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials. (2019) (161)
- Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention (2018) (156)
- Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF. (2011) (152)
- Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation (2014) (151)
- Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. (2009) (149)
- Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. (2014) (148)
- High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. (2014) (148)
- Results of a reevaluation of cardiovascular outcomes in the RECORD trial. (2013) (147)
- Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS (2016) (146)
- Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. (2009) (141)
- Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial. (2015) (139)
- APPRAISE 2. Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome for the APPRAISE-2 Investigators* (2011) (136)
- A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial (2017) (136)
- Left Ventricular Systolic Dysfunction, Heart Failure, and the Risk of Stroke and Systemic Embolism in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial (2013) (136)
- Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial. (2016) (136)
- A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial (2017) (136)
- Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. (2014) (134)
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack (2012) (133)
- New-onset atrial fibrillation and warfarin initiation: High risk periods and implications for new antithrombotic drugs (2010) (132)
- Digoxin and Mortality in Patients With Atrial Fibrillation. (2018) (131)
- Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes: A Substudy From the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial (2012) (130)
- Relationship Between Vein Graft Failure and Subsequent Clinical Outcomes After Coronary Artery Bypass Surgery (2012) (129)
- Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial (2016) (125)
- International variation in and factors associated with hospital readmission after myocardial infarction. (2012) (122)
- Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. (2019) (119)
- Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. (2020) (115)
- I Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia (2013) (115)
- Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018 (2019) (112)
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review. (2019) (111)
- Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial. (2017) (109)
- High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (2013) (109)
- Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. (2012) (107)
- Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry (2013) (106)
- Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial (2018) (100)
- Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. (2011) (96)
- Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial (2021) (96)
- Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery: a meta-analysis of 1,190 patients. (2014) (95)
- Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial (2019) (95)
- Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial. (2014) (89)
- Saphenous Vein Grafts With Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery: One-Year Graft Failure and Five-Year Outcomes From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial (2011) (88)
- Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. (2013) (87)
- Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial (2016) (86)
- Surgical Revascularization Is Associated With Maximal Survival in Patients With Ischemic Mitral Regurgitation: A 20-Year Experience (2014) (85)
- A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score (2017) (85)
- Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? (2010) (84)
- Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients. (2012) (84)
- Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial. (2016) (83)
- Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial. (2012) (82)
- Risks and Benefits of Anticoagulation in Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry (2013) (82)
- Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. (2017) (81)
- Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial. (2017) (80)
- The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction. (2012) (79)
- 6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias. (2015) (78)
- Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation (2016) (78)
- Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study (2016) (78)
- Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation (2020) (74)
- Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial (2020) (73)
- Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry. (2018) (73)
- Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial. (2020) (73)
- Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. (2015) (72)
- Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation (2016) (71)
- Apixaban Compared with Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the ARISTOTLE Trial (2015) (69)
- Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention (2020) (68)
- Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial (2019) (67)
- Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial (2015) (67)
- Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry. (2014) (66)
- Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial. (2019) (65)
- Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis (2013) (64)
- Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. (2014) (64)
- Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial (2017) (62)
- Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis. (2020) (61)
- Diagnosis and Treatment of Acute Coronary Syndromes: A Review. (2022) (61)
- Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trial. (2012) (61)
- Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update. (2021) (61)
- Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trial. (2011) (61)
- Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight. (2019) (59)
- Mechanical Ventilation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Observational Study (2016) (59)
- Red versus white thrombi in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: clinical and angiographic outcomes. (2012) (58)
- Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease (2020) (58)
- Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting. (2010) (57)
- Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease (2020) (57)
- Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial. (2022) (56)
- Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis. (2021) (56)
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (2018) (55)
- Diretrizes Brasileiras de antiagregantes plaquetários e anticoagulantes em cardiologia (2013) (55)
- The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study (2017) (54)
- Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. (2013) (53)
- Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. (2020) (53)
- Central venous pressure after coronary artery bypass surgery: does it predict postoperative mortality or renal failure? (2013) (53)
- Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. (2016) (52)
- Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial. (2015) (52)
- Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation (2016) (51)
- Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction (2020) (51)
- Anti-inflammatory effect of physical training in heart failure: role of TNF-alpha and IL-10. (2009) (50)
- Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction. (2012) (50)
- Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes. (2013) (50)
- Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi‐morbidity: Insights from the ARISTOTLE trial (2019) (49)
- Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial (2014) (49)
- Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. (2020) (49)
- Relationship of the Time Interval Between Cardiac Catheterization and Elective Coronary Artery Bypass Surgery With Postprocedural Acute Kidney Injury (2011) (48)
- New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry). (2013) (48)
- Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy. (2013) (48)
- Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial. (2019) (48)
- Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study. (2013) (47)
- II Diretriz de Avaliação Perioperatória da Sociedade Brasileira de Cardiologia (2011) (47)
- Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial. (2008) (46)
- Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) (2018) (46)
- Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial (2019) (46)
- Hospital length of stay in patients with non-ST-segment elevation myocardial infarction. (2012) (46)
- Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial (2016) (46)
- Diagnosing acute myocardial infarction in patients with left bundle branch block. (2011) (46)
- Zika and Chikungunya Virus and Risk for Venous Thromboembolism (2019) (45)
- Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial (2017) (45)
- Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease. (2013) (45)
- Atorvastatin for high‐risk statin‐naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial (2017) (45)
- First-Ever Stroke and Transient Ischemic Attack Incidence and 30-Day Case-Fatality Rates in a Population-Based Study in Argentina (2016) (44)
- Risk factors for mortality in patients admitted to intensive care units with pneumonia (2016) (44)
- Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial (2019) (44)
- Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial. (2019) (44)
- Comparative Effectiveness of Hybrid Coronary Revascularization vs Coronary Artery Bypass Grafting. (2015) (44)
- Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the PREVENT IV Trial (2015) (43)
- Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. (2019) (43)
- Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results. (2012) (43)
- Do Omega-3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials (2011) (43)
- Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials. (2010) (43)
- Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial. (2018) (43)
- Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial. (2020) (42)
- Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy (2017) (42)
- Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update. (2019) (42)
- Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis. (2021) (42)
- Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial (2018) (42)
- Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. (2015) (41)
- Stroke After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: Timing, Characteristics, and Clinical Outcomes (2013) (41)
- Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials (2021) (41)
- Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial. (2015) (41)
- Cumulative incidence of death and rehospitalization among the elderly in the first year after NSTEMI. (2015) (40)
- Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes. (2010) (40)
- Randomized Trials Versus Common Sense and Clinical Observation (2020) (39)
- Direct Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials with Interaction Testing by Age and Sex. (2022) (39)
- Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis (2020) (38)
- Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes. (2012) (38)
- Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician (2011) (38)
- Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation (2010) (38)
- Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials. (2019) (38)
- Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial. (2016) (37)
- Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights From the APPRAISE-2 Trial. (2015) (37)
- Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation (2019) (37)
- Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. (2020) (37)
- Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis (2018) (37)
- Saphenous vein graft failure and clinical outcomes: toward a surrogate end point in patients following coronary artery bypass surgery? (2013) (37)
- Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve. (2020) (36)
- Use and Associated Risks of Concomitant Aspirin Therapy with Oral Anticoagulation in Patients with Atrial Fibrillation: Insights from the ORBIT-AF Registry (2013) (36)
- Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic? (2020) (36)
- Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial. (2020) (35)
- Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI. (2020) (35)
- Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility. (2011) (34)
- Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial (2017) (33)
- Antithrombotic Therapy Use at Discharge and 1 Year in Patients With Atrial Fibrillation and Acute Stroke: Results From the AVAIL Registry (2011) (33)
- Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy. (2013) (33)
- Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes (2018) (33)
- Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial (2018) (32)
- Naproxen as prophylaxis against atrial fibrillation after cardiac surgery: the NAFARM randomized trial. (2011) (31)
- International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation. (2011) (31)
- Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction. (2012) (30)
- Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes (2019) (30)
- Implementation of a Regional Network for ST‐Segment–Elevation Myocardial Infarction (STEMI) Care and 30‐Day Mortality in a Low‐ to Middle‐Income City in Brazil: Findings From Salvador's STEMI Registry (RESISST) (2018) (30)
- Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy. (2011) (30)
- Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes (2017) (30)
- Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≥65 years with multivessel coronary artery disease. (2014) (29)
- Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. (2021) (29)
- Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration. (2020) (29)
- Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020 (2020) (28)
- Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease. (2014) (28)
- Identifying patients at risk for premature discontinuation of thienopyridine after coronary stent implantation. (2011) (28)
- Effects of Sodium-Glucose Cotransporter 1 and 2 Inhibitors on Cardiovascular and Kidney Outcomes in Type 2 Diabetes: A Meta-analysis Update. (2020) (28)
- Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial. (2015) (27)
- Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial. (2020) (27)
- Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study). (2014) (27)
- Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes. (2016) (26)
- Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial (2012) (26)
- The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review (2017) (26)
- Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy. (2018) (26)
- Late-onset Bloodstream Infections in Hospitalized Term Infants (2014) (25)
- Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial. (2015) (25)
- Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial (2021) (25)
- Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes. (2012) (25)
- Marital History and Survival After Stroke (2016) (24)
- Incidence and Outcomes Associated With Early Heart Failure Pharmacotherapy in Patients With Ongoing Cardiogenic Shock (2014) (24)
- Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial (2018) (24)
- Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer (2021) (24)
- Patterns of discharge antiplatelet therapy and late outcomes among 8,582 patients with bleeding during acute coronary syndrome: a pooled analysis from PURSUIT, PARAGON-A, PARAGON-B, and SYNERGY. (2010) (24)
- Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry. (2010) (23)
- Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document. (2019) (23)
- Cardiopulmonary exercise and 6-min walk tests as predictors of quality of life and long-term mortality among patients with heart failure due to Chagas disease. (2013) (23)
- Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. (2016) (23)
- Renal sympathetic denervation and ventricular arrhythmias: a case of electrical storm with multiple renal arteries. (2014) (23)
- Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis. (2012) (23)
- Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding (2019) (23)
- Stroke prevention in atrial fibrillation: re-defining ‘real-world data’ within the broader data universe (2018) (23)
- Antiplatelet therapy in older adults with non-ST-segment elevation acute coronary syndrome: considering risks and benefits. (2009) (22)
- Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial (2018) (22)
- Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial. (2019) (22)
- Abstract 17277: Apixaban Use in Patients With Atrial Fibrillation With Bioprosthetic Valves: Insights From ARISTOTLE (2015) (22)
- II Guidelines for perioperative evaluation of the Brazilian Society of Cardiology. (2011) (22)
- Endothelial function in patients with slow coronary flow and normal coronary angiography (2012) (22)
- Natriuretic peptides and long-term mortality in patients with severe aortic stenosis. (2012) (22)
- Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: study design and conduct. (2013) (22)
- Swyer-James-MacLeod syndrome in a surgically treated child: a case report and brief literature review. (2012) (21)
- Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non–ST-Segment–Elevation Acute Coronary Syndromes Clinical Trials (2016) (21)
- Perioperative management of anticoagulation: guidelines translated for the clinician (2009) (21)
- Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy (2013) (21)
- COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial (2020) (20)
- Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. (2012) (20)
- Serious infections among unselected patients with ST-elevation myocardial infarction treated with contemporary primary percutaneous coronary intervention. (2016) (20)
- Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing?: an analysis of 107,096 patients from the National Cardiovascular Data Registry's ICD Registry. (2012) (20)
- Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. (2013) (20)
- Ankle-brachial index as a predictor of coronary disease events in elderly patients submitted to coronary angiography (2013) (20)
- Transfer Times and Outcomes in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Interhospital Transfer for Primary Percutaneous Coronary Intervention: APEX-AMI Insights (2012) (20)
- Treating periodontal disease in patients with myocardial infarction: A randomized clinical trial. (2019) (20)
- Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician (2008) (19)
- Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome (2017) (19)
- Treatment of venous thromboembolism: guidelines translated for the clinician (2009) (19)
- History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. (2016) (19)
- Splanchnic Nerve Block Mediated Changes in Stressed Blood Volume in Heart Failure. (2021) (19)
- Meta-Analysis of Intracranial Hemorrhage in Acute Coronary Syndromes: Incidence, Predictors, and Clinical Outcomes (2015) (19)
- Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. (2014) (19)
- Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial (2017) (19)
- Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation: Meta-Analysis of Phase III Trials (2018) (19)
- Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin (2017) (19)
- Endoscopic Harvesting Device Type and Outcomes in Patients Undergoing Coronary Artery Bypass Surgery (2014) (19)
- North American Thrombosis Forum, AF Action Initiative Consensus Document. (2016) (19)
- Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2020) (19)
- Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021 (2021) (18)
- Nonsteroidal Anti-Inflammatory Drugs and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery. (2017) (18)
- Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndrome (ACS) and Diabetes—Prespecified Analyses of ODYSSEY OUTCOMES (2018) (18)
- The high cost of critical care unit over‐utilization for patients with NSTE ACS (2018) (18)
- Prevalence of atrial fibrillation and stroke risk assessment based on telemedicine screening tools in a primary healthcare setting. (2019) (18)
- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis (2022) (18)
- Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial (2017) (18)
- Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time (2017) (18)
- Antiplatelet agents in cardiovascular disease (2011) (18)
- Linking stroke-induced heart injury and neurogenic atrial fibrillation: a hypothesis to be proven. (2018) (18)
- Evaluation of self-perception of mechanical ventilation knowledge among Brazilian final-year medical students, residents and emergency physicians (2017) (18)
- Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial (2019) (17)
- 'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). (2019) (17)
- Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation (2018) (17)
- Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial (2017) (17)
- Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure (2021) (17)
- Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial. (2016) (17)
- Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine. (2018) (17)
- Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial (2021) (17)
- Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial. (2010) (17)
- Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial (2017) (17)
- Effect of a Quality Improvement Intervention on Adherence to Therapies for Patients With Acute Ischemic Stroke and Transient Ischemic Attack: A Cluster Randomized Clinical Trial. (2019) (17)
- Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials (2019) (16)
- Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting (2013) (16)
- SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation (2020) (16)
- Gaps in Evidence‐Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease (2021) (16)
- Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: a systematic review. (2014) (16)
- The First Brazilian Registry of Hypertension (2018) (16)
- Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis (2020) (15)
- Rumo ao Consenso Internacional de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência 2010 da Aliança Internacional dos Comitês de Ressuscitação (2010) (15)
- The Preservation and Handling of Vein Grafts in Current Surgical Practice: Findings of a Survey Among Cardiovascular Surgeons of Top-Ranked US Hospitals. (2015) (15)
- Efficacy and Safety of Apixaban in Patients Following Cardioversion for Atrial Fibrillation: Insights from the ARISTOTLE trial (2013) (15)
- Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial. (2013) (15)
- Effect of Once‐Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial (2018) (15)
- Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patients undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial. (2020) (15)
- Admission International Normalized Ratio Levels, Early Treatment Strategies, and Major Bleeding Risk Among Non–ST-Segment–Elevation Myocardial Infarction Patients on Home Warfarin Therapy: Insights From the National Cardiovascular Data Registry (2012) (15)
- Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction. (2019) (15)
- Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation (2020) (15)
- Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction (2021) (15)
- Practical and clinical considerations in assessing patients with atrial fibrillation for switching to non-vitamin K antagonist oral anticoagulants in primary care (2015) (14)
- New Approaches to Conducting Randomized Controlled Trials. (2020) (14)
- Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)–Coalition IV trial (2021) (14)
- Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial (2017) (14)
- Apixaban and warfarin are associated with a low risk of stroke following cardioversion for atrial fibrillation : results from the ARISTOTLE Trial (2012) (14)
- Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk. (2011) (14)
- Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial (2022) (14)
- Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST‐elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial (2018) (13)
- Posicionamento sobre Diagnóstico e Tratamento da Amiloidose Cardíaca – 2021 (2021) (13)
- International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial (2017) (13)
- Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome (2015) (13)
- [Intensive care of postoperative patients in bariatric surgery]. (2007) (13)
- Translation of acute coronary syndrome therapies: from evidence to routine clinical practice. (2015) (13)
- Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial). (2019) (13)
- An evaluation of the professional, social and demographic profile and quality of life of physicians working at the Prehospital Emergency Medical System (SAMU) in Brazil (2014) (13)
- Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial (2021) (12)
- Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial (2019) (12)
- Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease (2018) (12)
- Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE): A Translational, Integrated, and Transdisciplinary Approach. (2017) (12)
- Program for the Epidemiological Evaluation of Stroke in Tandil, Argentina (PREVISTA) Study: Rationale and Design (2013) (12)
- Metabolic syndrome and risk of stroke (2018) (12)
- Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials. (2018) (12)
- Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry). (2009) (12)
- Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease. (2018) (12)
- Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation (2020) (12)
- Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery. (2014) (11)
- P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention (2022) (11)
- Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial (2019) (11)
- Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial (2018) (11)
- Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials. (2018) (11)
- Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation (2021) (11)
- An international cluster‐randomized quality improvement trial to increase the adherence to evidence‐based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE Trial (2019) (11)
- Serial measurement of interleukin‐6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE‐LY trials (2020) (11)
- IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial (2021) (11)
- Usefulness of Extended-FAST (EFAST-Extended Focused Assessment with Sonography for Trauma) in critical care setting. (2010) (11)
- Evidence-based therapy prescription in high-cardiovascular risk patients: the REACT study. (2013) (11)
- Selection of Stent Type in Patients With Atrial Fibrillation Presenting With Acute Myocardial Infarction: An Analysis From the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry—Get With the Guidelines (2017) (10)
- Chronic obstructive pulmonary disease and cardiovascular risk: insights from the NAVIGATOR trial. (2014) (10)
- Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group. (2019) (10)
- Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial. (2020) (10)
- Brazilian Society of Cardiology Guidelines on Unstable Angina and Acute Myocardial Infarction without ST-Segment Elevation - 2021. (2021) (10)
- Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation (2021) (10)
- A multifaceted intervention to narrow the evidence-based gap in the treatment of acute coronary syndromes: rationale and design of the Brazilian Intervention to Increase Evidence Usage in Acute Coronary Syndromes (BRIDGE-ACS) cluster-randomized trial. (2012) (10)
- Cardiac troponin release following hybrid coronary revascularization versus off-pump coronary artery bypass surgery. (2014) (10)
- A time-series analysis of the relation between unemployment rate and hospital admission for acute myocardial infarction and stroke in Brazil over more than a decade. (2016) (10)
- EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO AGE FOR STROKE PREVENTION IN ATRIAL FIBRILLATION (2013) (10)
- Improvement in quality indicators using NCDR® registries: First international experience. (2018) (10)
- Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis (2016) (10)
- Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials (2020) (10)
- The detection and treatment of subclinical atrial fibrillation: evaluating the IMPACT of a comprehensive strategy based on remote arrhythmia monitoring. (2015) (10)
- Efficacy and Safety of Apixaban Compared with Warfarin at Different Levels of Predicted INR Control for Stroke Prevention in Atrial Fibrillation (2013) (10)
- Association Between Delays in Mechanical Ventilation Initiation and Mortality in Patients With Refractory Cardiogenic Shock. (2020) (10)
- Stroke Prevention in Atrial Fibrillation (2013) (10)
- Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. (2019) (10)
- Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: The RECALL study. (2016) (10)
- APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL (2013) (10)
- Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial. (2022) (10)
- Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document. (2018) (10)
- Obesity, Diabetes, and Acute Coronary Syndrome: Differences Between Asians and Whites. (2017) (9)
- Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease (2022) (9)
- Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial (2022) (9)
- A Brazilian perspective for the use of bovine heparin in open heart surgery. (2016) (9)
- The usefulness of T-wave peak to T-wave end interval in identifying malignant arrhythmias in patients with Chagas disease. (2013) (9)
- Coronary embolism and calcified aortic valve: is there a correlation? (2012) (9)
- Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. (2022) (9)
- APIXABAN IS EFFICACIOUS AND SAFE IN PATIENTS WITH ATRIAL FIBRILLATION USING CONCOMITANT AMIODARONE: AN ANALYSIS FROM THE ARISTOTLE TRIAL (2013) (9)
- Antithrombotic therapy for ischemic stroke: guidelines translated for the clinician (2010) (9)
- Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease. (2014) (9)
- Heart failure survival score in patients with Chagas disease: correlation with functional variables. (2012) (9)
- A clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AF): design and rationale. (2016) (9)
- Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled” trial (TOCIBRAS) (2020) (9)
- Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial. (2015) (9)
- Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials. (2019) (8)
- Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillation (2014) (8)
- Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome (2018) (8)
- Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients (2022) (8)
- Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial. (2017) (8)
- Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience (2018) (8)
- Ablação da atividade simpática renal com cateter de ponta irrigada: uma opção atraente? (2013) (8)
- A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention (2019) (8)
- Clinical outcomes and need for intensive care after non-ST-segment-elevation myocardial infarction. (2020) (8)
- International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin (2019) (8)
- I RBH - First Brazilian Hypertension Registry (2016) (8)
- Glycemic control in patients undergoing coronary artery bypass graft surgery: Clinical features, predictors, and outcomes (2017) (8)
- Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review (2020) (8)
- Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH (2022) (8)
- Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial (2022) (8)
- Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE (2021) (8)
- A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19 (2022) (8)
- Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial. (2015) (8)
- Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. (2019) (8)
- A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE (2013) (8)
- Relation of Postdischarge Care Fragmentation and Outcomes in Transcatheter Aortic Valve Implantation from the STS/ACC TVT Registry. (2019) (8)
- Bilateral macular hemorrhage as a complication of drug-induced anemia: a case report (2009) (7)
- The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia (2017) (7)
- A nationwide survey on perception, experience, and expectations of hybrid coronary revascularization among top-ranked US hospitals. (2015) (7)
- Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial. (2019) (7)
- Increased levels of D-dimer identify patients with atrial fibrillation at high risk for bleeding an ARISTOTLE substudy (2012) (7)
- EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN PATIENTS TAKING CONCOMITANT ASPIRIN (2012) (7)
- The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials. (2015) (7)
- Efficacy and safety of apixaban compared with warfarin in relation to renal function over time in patients with atrial fibrillation : Insights from the ARISTOTLE trial (2015) (7)
- Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021. (2021) (7)
- Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. (2022) (7)
- Use of apixaban and warfarin in patients undergoing invasive procedures : insights from ARISTOTLE (2013) (7)
- Association Between Endoscopic vs Open Vein-Graft Harvesting and Mortality, Wound Complications, and Cardiovascular Events in Patients Undergoing CABG Surgery (2013) (7)
- Antithrombotic therapy after acute coronary syndrome and/or percutaneous coronary intervention in atrial fibrillation: finding the sweet spot. (2019) (7)
- Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the ARISTOTLE trial (2019) (7)
- Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention. (2022) (7)
- Antithrombotic therapy in heparin-induced thrombocytopenia: guidelines translated for the clinician (2012) (7)
- Atrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke prevention. (2014) (7)
- Prescrição de terapias baseadas em evidências para pacientes de alto risco cardiovascular: estudo REACT (2013) (7)
- Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated Collection (2017) (7)
- Relation of Activated Clotting Times During Percutaneous Coronary Intervention to Outcomes. (2016) (7)
- Survival After Invasive or Conservative Management of Stable Coronary Disease (2022) (7)
- The role of diabetes mellitus in the composition of coronary thrombi in patients presenting with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. (2016) (7)
- Prophylaxis for venous thromboembolism: guidelines translated for the clinician (2010) (7)
- Changes in Left Ventricular Mechanics After Sleeve Gastrectomy (2019) (6)
- Association of Non-Alcoholic Fatty Liver Disease with In-Hospital Outcomes in Primary Heart Failure Hospitalizations with Reduced or Preserved Ejection Fraction. (2022) (6)
- Anticoagulation in COVID-19 (2020) (6)
- Treatment of Older Patients with Atrial Fibrillation by Morbidity Burden. (2020) (6)
- Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial. (2022) (6)
- The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up Study (2018) (6)
- Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome. (2017) (6)
- Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. (2016) (6)
- Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention. (2013) (6)
- Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE (2018) (6)
- Regional differences in presentation and antithrombotic treatment of patients with atrial fibrillation: Baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with atrial fibrillation (IMPACT-AF). (2017) (6)
- Cause of Death Among Patients With Peripheral Artery Disease (2020) (6)
- Ultrasound guidance for arterial (other than femoral) catheterisation in adults (2020) (6)
- Clinical consequences of bleeding among individuals with a recent acute coronary syndrome: Insights from the APPRAISE-2 trial. (2019) (6)
- Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation (2020) (6)
- Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas (2021) (6)
- Major Adverse Cardiovascular Events After 12 Months Among Patients With Acute Coronary Syndrome Receiving Loading Doses of Atorvastatin Prior to Planned PCI. (2020) (6)
- Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial (2019) (6)
- Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial (2022) (6)
- Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention. (2019) (6)
- Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients A Randomized Clinical Trial (2022) (6)
- BODY MASS INDEX AND OUTCOMES WITH APIXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ARISTOTLE (APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION) TRIAL (2015) (6)
- Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE‐2 trial (2018) (6)
- High-quality evidence to inform clinical practice (2019) (6)
- Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling (2022) (6)
- Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel” (2014) (6)
- Anger control and cardiovascular outcomes. (2013) (6)
- Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial (2021) (6)
- Antithrombotic therapy in acute coronary syndromes: guidelines translated for the clinician (2010) (6)
- Gastroesophageal reflux and atrial fibrillation: is there any correlation? (2012) (5)
- Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. (2020) (5)
- Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation (2022) (5)
- Discharge timing and outcomes after uncomplicated non–ST‐segment elevation acute myocardial infarction (2018) (5)
- Hydroxychloroquine alone or in combination with azithromycin to prevent major clinical events in hospitalised patients with coronavirus infection (COVID-19): rationale and design of a randomised, controlled clinical trial (2020) (5)
- A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial. (2020) (5)
- Use of Apixaban and Warfarin in Patients Undergoing Invasive Procedures: Insights From Aristotle (2013) (5)
- ADMA and SDMA predict outcomes in patients with chronic atrial fibrillation: an ARISTOTLE substudy (2013) (5)
- Effects of perioperative statin use on cardiovascular complications in patients submitted to non-cardiac surgery: protocol for a systematic review, meta-analysis, and trial sequential analysis (2017) (5)
- Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial. (2012) (5)
- Paraneoplastic pemphigus associated with non-Hodgkin lymphoma. (2008) (5)
- Net‐clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more (2019) (5)
- Peripheral blood metabolite profiles associated with new onset atrial fibrillation (2019) (5)
- Comparison of Outcomes and Frequency of Graft Failure With Use of Free Versus In Situ Internal Mammary Artery Bypass Conduits (from the PREVENT IV Trial). (2019) (5)
- Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies (2021) (5)
- Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis. (2020) (5)
- Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial (2016) (5)
- Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23–25, 2008, Sao Paulo, Brazil (2009) (4)
- Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial (2022) (4)
- Statins in adult patients with HIV (2018) (4)
- Inflammation and circulating endothelial progenitor cells in patients with coronary artery disease and residual platelet reactivity (2012) (4)
- Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism (2016) (4)
- Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial. (2019) (4)
- Oral anticoagulation: a step toward solving the puzzle of dementia related to atrial fibrillation? (2018) (4)
- The association between cardiac intensive care unit mechanical ventilation volumes and in-hospital mortality. (2021) (4)
- Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial (2021) (4)
- Effect of Apixaban on All-Cause Mortality in Atrial Fibrillation: An Imputed Placebo Analysis (P5.003) (2014) (4)
- Effects of apixaban compared with warfarin as gain in event-free time – a novel assessment of the results of the ARISTOTLE trial (2019) (4)
- Usefulness and Cost-Effectiveness of Universal Echocardiographic Contrast to Detect Left Ventricular Thrombus in Patients with Heart Failure and Reduced Ejection Fraction. (2018) (4)
- Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients (2022) (4)
- Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia (2007) (4)
- 900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial (2011) (4)
- Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14–16, 2010, São Paulo, Brazil (2010) (4)
- Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS. (2019) (4)
- Update on cardiopulmonary resuscitation: a review for the internist (2012) (4)
- Highlights from the 56th annual scientific sessions of the American College of Cardiology: March 25 to 27, 2007, Atlanta, Georgia. (2007) (4)
- Pandemonium During the Pandemic: What is the Role of Health and Science Professionals? (2020) (4)
- Use of Direct Oral Anticoagulants in Special Populations. (2016) (4)
- Association of the left common ostium with clinical outcome after pulmonary vein isolation in atrial fibrillation (2020) (4)
- DIABETIC PATIENTS HAVE SIMILAR VEIN GRAFT FAILURE AT 1 YEAR, BUT HIGHER 5-YEAR MORTALITY THAN NON-DIABETIC PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY: INSIGHTS FROM THE PREVENT-IV TRIAL (2012) (4)
- The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges (2022) (4)
- Pooled analysis of adverse event collection from 4 acute coronary syndrome trials. (2016) (3)
- Clinical Events Classification (CEC) in Clinical Trials: Report on the Current Landscape and Future Directions - Proceedings from the CEC Summit 2018. (2021) (3)
- Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice. (2018) (3)
- TICAGRELOR VERSUS CLOPIDOGREL IN WOMEN WITH ACUTE CORONARY SYNDROMES – A SUBSTUDY FROM THE PROSPECTIVE RANDOMIZED PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL (2012) (3)
- Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect (2017) (3)
- A NEW BIOMARKER BASED RISK SCORE FOR PREDICTING STROKE OR SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION: THE BEST RISK SCORE (2014) (3)
- Cardiovascular clinical research in South America. (2013) (3)
- Abstract 16800: Anemia Predicts Bleeding and Mortality, but Not Stroke, in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial (2014) (3)
- Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials (2021) (3)
- Accuracy of Post-thrombolysis ST-segment Reduction as an Adequate Reperfusion Predictor in the Pharmaco-Invasive Approach. (2021) (3)
- Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery (2018) (3)
- ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and Design of the GUARD-AF Randomized Trial of Screening for Atrial Fibrillation with a 14-day Patch-Based Continuous ECG Monitor. (2022) (3)
- Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation: Insights From the American Heart Association Get With The Guidelines–Atrial Fibrillation Program (2018) (3)
- Cardiovascular adverse events in the drug‐development program of bupropion for smoking cessation: A systematic retrospective adjudication effort (2017) (3)
- A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation. (2020) (3)
- Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials (2021) (3)
- Voice-based screening for SARS-CoV-2 exposure in cardiovascular clinics (2021) (3)
- Promise of Factor Xa Inhibition in Atrial Fibrillation (2012) (3)
- International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS. (2019) (3)
- Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials. (2022) (3)
- The safety and efficacy of apixaban: where do we stand in 2013? (2013) (3)
- Cardiac Arrest and Cardiopulmonary Resuscitation (CPR) Knowledge at an Academic Research Organization in Durham, NC (2015) (3)
- Galectin-3 Associated with Severe Forms and Long-term Mortality in Patients with Chagas Disease. (2021) (3)
- Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation (2020) (3)
- Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multistate model. (2022) (3)
- Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery (2017) (3)
- COVID-19 in Brazil: the headlines should be about science (2020) (3)
- Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE‐PCI Trial (2018) (3)
- Abstract 16645: Worse Renal Function is Associated with Markedly Worse Outcomes Among STEMI Patients Undergoing Primary PCI: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) Trial (2012) (3)
- Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate (2016) (3)
- Correlation of Quantitated Intravascular Volume with Blood Pressure in Patients with Systemic Hypertension (2019) (3)
- Abstract 19325: Betrixaban Reduces the Burden of Multiple Symptomatic Venous Thromboembolic Events in the APEX Trial (2016) (3)
- Morphine and Clinical Outcomes in Patients with ST segment elevation Myocardial Infarction Treated with Fibrinolytic and Antiplatelet Therapy: Insights from the TREAT Trial. (2022) (3)
- Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial. (2021) (3)
- Global Representation of Heart Failure Clinical Trial Leaders, Collaborators, and Enrolled Participants: A Bibliometric Review 2000-2020. (2021) (3)
- Evaluation of 1-Year Follow-up of Patients Included in the Registry of Clinical Practice in Patients at High Cardiovascular Risk (REACT). (2020) (3)
- Abstract 14771: Apixaban versus warfarin in Patients with Atrial Fibrillation in relation to Prior Warfarin Use: Insights from the ARISTOTLE trial (2012) (3)
- Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials (2020) (3)
- Atrial fibrillation: what do we know about screening and what do we not know about treatment? (2019) (3)
- Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019? (2019) (3)
- Response to Letters Regarding Article, "Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV". (2015) (3)
- Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events (2020) (3)
- Epicardial adipose tissue and metabolic syndrome (2018) (3)
- Polineuropatia no Paciente Crítico: Um Diagnóstico Comum em Medicina Intensiva?* Polyneuropathy in the Critical Ill patient: A common Diagnosis in Intensive Care Medicine? (2006) (3)
- POORLY CONTROLLED BLOOD PRESSURE IS INDEPENDENTLY ASSOCIATED WITH A 50% HIGHER RISK OF STROKE OR SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL (2014) (2)
- Antivirals for adult patients hospitalized with SARS-CoV-2 infection: A randomized, Phase II/III, multicenter, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn: protocol and statistical analysis plan (2022) (2)
- EXTERNAL VALIDATION OF THE BIOMARKER-BASED ABC-BLEEDING RISK SCORE FOR ATRIAL FIBRILLATION (2016) (2)
- Total plasmatic homocysteine and von Willebrand factor in experimental diabetes mellitus. (2007) (2)
- The atrial FibriLlatiOn real World management registry in the Middle East and Africa: design and rationale (2020) (2)
- Clinical and Economic Outcomes Among Non-Valvular Atrial Fibrillation Patients with Coronary Artery Disease and/or Peripheral Artery Disease. (2021) (2)
- Response to letter regarding article, "surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience". (2015) (2)
- Letter by Hess et al Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring". (2016) (2)
- Non-Vitamin K Antagonists versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Valves: a Systematic Review and Meta-Analysis. (2021) (2)
- Less non-major bleeding with apixaban versus warfarin among patients with atrial fibrillation : insights from the ARISTOTLE trial (2015) (2)
- Antiplatelet Therapy in Patients with Atrial Fibrillation: A Systematic Review and Metaanalysis of Randomized Trials. (2021) (2)
- Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial (2013) (2)
- Highlights from the II international symposium of thrombosis and anticoagulation (ISTA), October 22–23, 2009, São Paulo, Brazil (2010) (2)
- Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial". (2016) (2)
- Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes. (2019) (2)
- Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease (2022) (2)
- 5770A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials (2017) (2)
- NOVEL PROGNOSTIC BIOMARKERS FOR ISCHEMIC STROKE IN PATIENTS WITH ATRIAL FIBRILLATION USING MULTIMARKER SCREENING: INSIGHTS FROM THE ARISTOTLE TRIAL (2018) (2)
- POSTOPERATIVE GLUCOSE CONTROL FOLLOWING CORONARY ARTERY BYPASS GRAFT SURGERY: PREDICTORS AND CLINICAL OUTCOMES (2013) (2)
- P858Women with stable coronary artery disease have better clinical outcomes than men, but this association is modified by degree of depression: insights from the STABILITY trial (2017) (2)
- Quality of life and long-term outcomes after hospitalization for COVID-19: Protocol for a prospective cohort study (Coalition VII) (2021) (2)
- Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes. (2022) (2)
- Levels of evidence supporting drug, device, and other recommendations in the American Heart Association/American College of Cardiology guidelines. (2020) (2)
- Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial (2022) (2)
- New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know? (2019) (2)
- Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". (2014) (2)
- ‘Choosing Wisely’ culture among Brazilian cardiologists (2018) (2)
- High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort study (2021) (2)
- COOrdinating CaRDIology CliNics RAndomized Trial of Interventions to Improve OutcomEs (COORDINATE) - Diabetes: Rationale and Design. (2022) (2)
- 118: MAJOR BLEEDING IN MEDICAL-SURGICAL CRITICALLY ILL PATIENTS IS ASSOCIATED WITH INCREASED USE OF BLOOD PRODUCTS, LONGER HOSPITAL STAY AND HIGHER MORTALITY (2012) (2)
- Management and clinical consequences of major bleeding in high-risk patients following an acute coronary syndrome. Is aspirin the problem? : Insights from the APPRAISE-2 trial (2015) (2)
- Erratum to: Risk factors for mortality in patients admitted to intensive care units with pneumonia (2016) (2)
- Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes. (2013) (2)
- APIXABAN COMPARED WITH WARFARIN IN PATIENTS WITH DIABETES AND NONVALVULAR ATRIAL FIBRILLATION IN THE ARISTOTLE TRIAL (2014) (2)
- Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: balance best with double antithrombotic therapy. (2020) (2)
- Development and validation of a questionnaire to assess the knowledge of mechanical ventilation in urgent care among students in their last-year medical course in Brazil (2019) (2)
- Rationale and design for a cluster randomized quality‐improvement trial to increase the uptake of evidence‐based therapies for patients at high cardiovascular risk: The BRIDGE‐Cardiovascular Prevention trial (2019) (2)
- Abstract 16415: Patterns of Atrial Fibrillation and Treatment Strategies Vary According to Provider Specialty Across Community Practice Settings: Findings From the ORBIT-AF Registry (2011) (2)
- Abstract 16741: The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group (2014) (2)
- A new biomarker based risk score for predicting major bleeding in atrial fibrillation - the ABC (age, biomarkers, current disease) risk score (2014) (2)
- Pandemônio Durante a Pandemia: Qual o Papel dos Profissionais da Saúde e a Ciência? (2020) (2)
- Acurácia da Redução do Segmento-ST Pós-Trombólise como Preditor de Reperfusão Adequada em Estratégia Fármaco-Invasiva (2021) (2)
- Galectina-3 Associada a Formas Graves e Mortalidade em Longo Prazo em Pacientes com Doença de Chagas (2021) (2)
- Ressuscitação no Brasil e no mundo e o ILCOR (Aliança Internacional dos Comitês de Ressuscitação): história e consenso 2010 de ressuscitação cardiopulmonar e emergências cardiovasculares (2010) (2)
- Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction (2016) (2)
- Chagas disease: still a neglected emergency? (2020) (2)
- Coronary Artery Fistula Causing Acute Myocardial Infarction and Right Ventricle Thrombus (2018) (2)
- Duplex ultrasound for surveillance of lower limb revascularisation (2021) (2)
- The ASCEND-ND trial: study design and participant characteristics (2021) (2)
- High Sensitivity Troponin I for Risk Assessment in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial (2013) (2)
- Choice of P2Y12 inhibitor and clinical outcomes in the AUGUSTUS study: support for an individualised approach (2020) (2)
- Conduct in nutrition on trauma for clinical (2012) (1)
- Abstract 1583: Differences in Bleeding Rates Accounts for All of the Excess Mortality in African Americans Compared With Caucasians With ST-Elevation Myocardial Infarction treated With Fibrinolysis (2009) (1)
- Abstract 15115: Reduction in Bleeding with Apixaban versus Warfarin is Consistent Across Subgroups and Locations: Insights from the ARISTOTLE Trial (2012) (1)
- Factors associated with uncontrolled blood pressure in hypertensive Brazilians (2022) (1)
- Efficacy and Safety of Vorapaxar in Elderly Patients With Non-ST-Segment Elevation Acute Coronary Syndrome : Insights From the TRACER Trial (2013) (1)
- P4797Novel prognostic biomarkers identified by proximity extension assay are associated with major bleeding in patients with atrial fibrillation on oral anticoagulation: insights from the ARISTOTLE trial (2018) (1)
- Chest Pain Network with Support of Telemedicine: Impact on Reperfusion Therapy and Clinical Outcomes After 8 Years of Experience (2020) (1)
- Abstract 15975: Multimorbidity is Associated With Greater Risk of Thromboembolism and Bleeding in Patients With Atrial Fibrillation but a Constant Benefit of Apixaban: Results From ARISTOTLE (2017) (1)
- Rationale and Design of the COVID-19 Outpatient Prevention Evaluation (COPE - Coalition V) Randomized Clinical Trial: Hydroxychloroquine vs. Placebo in Non-Hospitalized Patients. (2022) (1)
- MAJOR BLEEDING IS AN INDEPENDENT PREDICTOR OF ONE-YEAR POST-DISCHARGE MORTALITY IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES (2010) (1)
- Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older (2021) (1)
- SEX DIFFERENCES IN STRESS TEST AND CCTA FINDINGS AND SYMPTOMS IN THE RANDOMIZED ISCHEMIA TRIAL (2020) (1)
- [Update on cardiopulmonary resuscitation: what changed with the new guidelines]. (2006) (1)
- Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. (2022) (1)
- HAS THE U.S. STOCK MARKET COLLAPSE IMPACTED CARDIOVASCULAR EVENT RATES (2010) (1)
- Predictors and Associated Clinical Outcomes of Low Cardiac Output Syndrome Following Cardiac Surgery: Insights from the LEVO-CTS Trial. (2022) (1)
- NKG2A Expression among CD8 Cells Is Associated with COVID-19 Progression in Hypertensive Patients: Insights from the BRACE CORONA Randomized Trial (2022) (1)
- Ultrasound guidance for arterial (other than femoral) catheterisation in adults. (2021) (1)
- Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure : insights from the ARISTOTLE trial (2015) (1)
- Apixaban after Acute Coronary Syndrome REPLY (2011) (1)
- Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), october 18–19, 2012, Belo Horizonte, Minas Gerais, Brazil (2013) (1)
- New Biomarkers Associated With Cardiovascular Death In Patients With Atrial Fibrillation Using Multimarker Screening : Insights From The Aristotle Trial (2018) (1)
- 864-P: Glycemic Control across eGFR Categories with the Dual SGLT1 and 2 Inhibitor Sotagliflozin in SCORED (2022) (1)
- Interleukin-6 and C-reactive protein and risk for cardiovascular events and death in anticoagulated patients with atrial fibrillation (2014) (1)
- Pharmacokinetics of apixaban in patients with end stage renal disease on hemodialysis and atrial fibrillation: results from the RENAL-AF trial (2020) (1)
- Epicardial adipose tissue and carotid artery disease (2018) (1)
- Abstract 16489: Idarucizumab is Effective and Safe in the Inhibition of Dabigatran Anticoagulation in Patients Presenting With a GastroIntestinal Bleeding: Insights From the RE-VERSE AD Study (2017) (1)
- Patients with atrial fibrillation treated with apixaban are less likely to discontinue study drug when compared with warfarin : insights from the ARISTOTLE trial (2016) (1)
- Late-breaking trials summary from the 2008 American College of Cardiology Scientific Sessions, March 29 to April 1, Chicago, IL (2008) (1)
- High-density lipoprotein-cholesterol functionality and metabolic syndrome (2018) (1)
- Atrial Fibrillation and Stroke Prevention (2015) (1)
- Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial. (2021) (1)
- Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial. (2022) (1)
- Physicians Declining Patient Enrolment Into Clinical Trials: Incidence And Insights (2012) (1)
- Commentary on the 2021 ASH Guidelines on use of anticoagulation in patients with COVID-19 being discharged from the hospital (2022) (1)
- Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop (2023) (1)
- REDUCTION OF TYPE 1 AND TYPE 2 MYOCARDIAL INFARCTIONS IN PATIENTS TREATED WITH ALIROCUMAB: INSIGHTS FROM THE ODYSSEY TRIAL (2019) (1)
- Anaphylaxis: recognition and management. A review for the general practitioner (2012) (1)
- Abstract 14643: Apixaban Plus Mono versus Dual Antiplatelet Therapy After Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial (2014) (1)
- Corrigendum to "Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial" [Am Heart J 169/6 (2015) 890-898]. (2017) (1)
- P3626Serial IL-6 levels and risk of death in anticoagulated patients with atrial fibrillation: Insights from the ARISTOTLE trial (2017) (1)
- Efficacy and safety of ticagrelor in patients with acute coronary syndrome and heart failure : insights from the platelet inhibition and patient outcomes (PLATO) trial (2014) (1)
- SHORTER HOSPITAL STAYS AND OUTCOMES AFTER NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (2014) (1)
- Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX (2021) (1)
- Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects? (2016) (1)
- ONE-YEAR MORTALITY INCREASED IN PATIENTS WITH PERI-PROCEDURAL MYOCARDIAL INFARCTION: INSIGHTS FROM THE CHAMPION TRIALS (2017) (1)
- Risk of events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the ARISTOTLE trial (2013) (1)
- Independence of Clinical Events Committees: A Consensus Statement from Clinical Research Organizations. (2022) (1)
- Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy (2021) (1)
- P3568Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial (2017) (1)
- Insulin Use and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery (2020) (1)
- Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy. (2022) (1)
- The efficacy of apixaban compared to warfarin in patients with atrial fibrillation with high coagulation activity despite anticoagulant treatment (2014) (1)
- Abstract 9904: Trends in Enrollment, Patient Characteristics, Treatments and Outcomes of Older Adults With Non-ST-segment Elevation Acute Coronary Syndromes (ACS) in Clinical Trials (2013) (1)
- [Chronicle myeloid leukemia and hiperviscosity syndrome: case report]. (2008) (1)
- SOTAGLIFLOZIN REDUCES TOTAL HOSPITALIZATIONS AND INCREASES DAYS ALIVE AND OUT OF HOSPITAL IN THE SOLOIST-WHF TRIAL (2021) (1)
- Abstract 16695: Percutaneous Coronary Intervention and Antiplatelet Therapy on Apixaban or Warfarin: Insights From the ARISTOTLE Trial (2016) (1)
- EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO CHADS2 AND HASBLED RISK SCORES FOR STROKE PREVENTION IN ATRIAL FIBRILLATION (2012) (1)
- Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial (2022) (1)
- NON-VITAMIN K ANTAGONISTS SHOULD BE PREFERRED OVER WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND BIOPROSTHETIC VALVES: A SYSTEMATIC REVIEW AND META-ANALYSIS (2021) (1)
- Risk of stroke, systemic embolism or death according to heart failure and left ventricular function status in patients with atrial fibrillation : results of the ARISTOTLE trial (2012) (1)
- [Liver ischemic necrosis and diabetes mellitus: case report]. (2007) (1)
- International variation in management and outcomes in high-risk patients following acute coronary syndromes: results from the APPRAISE-2 trial (2013) (1)
- Subclinical Atrial Fibrillation (2019) (1)
- Renal denervation for the treatment of ventricular arrhythmias: A systematic review and meta‐analysis (2021) (1)
- Rivaroxaban in Outpatients with Mild or Moderate COVID-19: Rationale and Design of the Study CARE (CARE - Coalition COVID-19 Brazil VIII). (2023) (1)
- Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events (2022) (1)
- Abstract 10658: Patients Receive Better Care in a Traditional Randomized Trial Setting Than in a Pragmatic Quality Improvement Study: Potential Implications for Improvements in Care (2021) (0)
- A systematic review of outcomes related to hybrid coronary revascularization in patients with multi-vessel coronary artery disease in the drug-eluting stent era (2013) (0)
- Gastroesophageal reflux and atrial fibrillation: is there any (2012) (0)
- Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) (2023) (0)
- Efficacy and safety of pharmacological interventions in epicardial adipose tissue: A protocol for systematic review and network meta-analysis (2018) (0)
- Abstract 19050: Does Type of Culprit Lesion Matter in Patients with Acute Coronary Syndrome and Prior Coronary Artery Bypass Graft Surgery Undergoing Percutaneous Coronary Intervention? (2012) (0)
- THE HIGH COST OF LOW ACUITY NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME ADMISSIONS TO THE CORONARY CARE UNIT: AN ANALYSIS OF NATIONAL POPULATION HEALTH DATA (2017) (0)
- P3631Determinants of antithrombotic treatment of patients with AF: baseline characteristics from a clustered randomized trial to IMProve treatment with AntiCoagulanTs in patients with AF (IMPACT-AF) (2017) (0)
- SUSTAINED VENTRICULAR ARRHYTHMIAS ADD PROGNOSTIC VALUE INDEPENDENT OF UNDERLYING RISK IN STEMI PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (2010) (0)
- Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scores. (2023) (0)
- ASYMMETRIC AND SYMMETRIC DIMETHYLARGININE ARE INEDEPENDENTLY ASSOCIATED WITH STROKE, BLEEDING AND DEATH IN ANTICOAGULATED PATIENTS WITH ATRIAL FIBRILLATION (2020) (0)
- Ticagrelor versus Clopidogrel in Patients with STEMI Treated with Fibrinolytic Therapy: TREAT Trial (2019) (0)
- Apixaban after acute coronary syndrome in patients with heart failure : insights from the APPRAISE-2 trial (2012) (0)
- AS05 Cardiac arrest Outcomes Data Evaluation – CODE registry: Brazilian registry of in-hospital cardiopulmonary resuscitation (2011) (0)
- REGIONAL VARIATION IN OUTCOMES IN PATIENTS WITH IMPAIRED FASTING GLUCOSE: INSIGHTS FROM THE NAVIGATOR TRIAL (2016) (0)
- Abstract 10050: Peripheral Blood Metabolic Profiles Predict the Future Occurrence of New Onset Atrial Fibrillation (2011) (0)
- 70Atrial fibrillation prevalence and care issues in brazilian public health: telemedicine data analysis (2018) (0)
- Abstract 8844: 10-Year Mortality is Very High, and Warfarin Use Very Low, in Patients with Myocardial Infarction and Atrial Fibrillation (2011) (0)
- Abstract 12777: More Bleeding but No Additional Efficacy with Increasing Age in High-risk ACS Patients Treated with Early vs. Delayed, Provisional Eptifibatide (2010) (0)
- Abstract 16978: A History of GI Bleeding is Associated With Increased Risk of Subsequent Bleeding, but Not Stroke: Insights From the ARISTOTLE Trial (2016) (0)
- Abstract 17205: Polypharmacy and the Impact of Apixaban on Clinical Events in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial (2015) (0)
- Destaques do VII international symposium of thrombosis and anticoagulation (ISTA) (2015) (0)
- Abstract 14862: Prediction of Myocardial Infarct Size Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention (2011) (0)
- MANAGEMENT OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH STROKE: WHERE DO WE STAND IN 2018? (2019) (0)
- APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL (2016) (0)
- Atorvastatin for High Risk Statin-Naïve Patients Undergoing Noncardiac Surgery : The LOAD Randomized Trial (2016) (0)
- Serious Infection Following Acute Myocardial Infarction: Incidence, Clinical Features, and Outcomes (2014) (0)
- “Incidence of and Outcomes Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention” Jerome Chambers - “Genetic Alterations Associated with Cryptorchidism” Wanda Averhart - “Clinical trial: A Multistrain Probiotic Preparation Significa (2009) (0)
- Abstract 13686: Implementing a Regionalized Integrated Network for ST-segment-Elevation Myocardial Infarction (STEMI) Care is Associated With Higher Use of Evidence-Based Medication and Better Survival Among STEMI Patients: Long-Term Results From the RESISST Registry (2015) (0)
- THE ATRIAL FIBRILLATION REAL-WORLD (RW) MANAGEMENT REGISTRY IN THE MIDDLE EAST & AFRICA (THE FLOW-AF REGISTRY): PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND OUTCOMES (2023) (0)
- Interpreting the TRITON Results in Light of the Event Adjudication Process (2009) (0)
- Abstract 12404: Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Normal Renal Function over Time: Insights From the ARISTOTLE Trial (2015) (0)
- Relationship between ventricular repolarization parameters and the inducibility of ventricular arrhythmias during electrophysiological study in patients with coronary artery disease (2020) (0)
- Abstract 17236: Intracranial Hemorrhage in Patients With Atrial Fibrillation in the ARISTOTLE Trial: Clinical Characteristics and Associated Outcomes (2015) (0)
- Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial (2022) (0)
- PREDICTION OF DEATH AND CONGESTIVE HEART FAILURE USING MULTIPLE CONCOMITANT ANGIOGRAPHIC BIOCHEMICAL AND ELECTROCARDIOGRAPHIC BIOMARKERS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION (2011) (0)
- Abstract 14726: Performance of the Novel Biomarker-Based ABC-Stroke Risk Score Over Time in Patients With Atrial Fibrillation (2016) (0)
- DUAL ANTIPLATELET THERAPY AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROMES (2014) (0)
- Abstract 14813: Pre-Treatment With Thienopyridines Reduces The Amount of Myonecrosis in Acute Coronary Syndrome Patients Invasively Managed: Insights from the CHAMPION trials (2010) (0)
- Abstract 17617: History of Bleeding and Outcomes with Apixaban versus Warfarin in Patients with Atrial Fibrillation in the ARISTOTLE Trial (2014) (0)
- Abstract 1519: Atrial Fibrillation Is Independently Associated With A High Risk of Death in Patients With Acute Coronary Syndromes (2007) (0)
- VEIN GRAFT FAILURE FOLLOWING CORONARY ARTERY BYPASS SURGERY: DOES IT MATTER? (2010) (0)
- Abstract 15664: Prior Oral Anticoagulant Status and Outcomes in Patients With Atrial Fibrillation With an Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention: Insights From the Augustus Trial (2020) (0)
- ABC-AF STROKE AND BLEEDING SCORES ARE USEFUL TOOLS TO ESTIMATE THE BALANCE BETWEEN BENEFITS AND RISKS WITH DIFFERENT ANTITHROMBOTIC TREATMENTS IN PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE AND RE-LY TRIALS (2022) (0)
- 4114Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy (2019) (0)
- Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial". (2021) (0)
- Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. (2021) (0)
- Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil (2018) (0)
- Kartagener's Syndrome. Case Report (2008) (0)
- Abstract P195: Long-Term Outcomes Associated with Hospital-Acquired Thrombocytopenia Among Patients with Acute Coronary Syndrome (2011) (0)
- Contents (2020) (0)
- Abstract 77: Balancing Risks and Benefits of Anticoagulation Therapy in Atrial Fibrillation in Community Practice: Results from the ORBIT-AF Registry (2012) (0)
- Abstract 10343: Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Peripheral Artery Disease and Non-valvular Atrial Fibrillation: Insights From the Aristotle Trial (2015) (0)
- P5793Faster heart rate is associated with significantly higher risk of death and hospitalization due to heart failure in patients with persistent or permanent atrial fibrillation: insights from ARISTOTLE (2018) (0)
- Highlights from the Ninth International Symposium of Thrombosis and Anticoagulation (ISTA IX), October 15, 2016, Salvador, Bahia, Brazil (2017) (0)
- CARDIAC REHABILITATION MIGHT HELP REFINING THE INDICATION OF HEART TRANSPLANTATION IN PATIENTS WITH ADVANCED HEART FAILURE (2020) (0)
- HOSPITAL VARIATION IN PERIOPERATIVE INSULIN USE AND GLUCOSE CONTROL IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFT SURGERY (2013) (0)
- The efficacy and safety of apixaban versus warfarin are preserved in patients with atrial fibrillation and extreme body weight: Insights from the ARISTOTLE Study (2018) (0)
- Abstract 12640: Discharge Warfarin is Underused in High Risk Atrial Fibrillation Patients With Myocardial Infarction (2010) (0)
- Saphenous Vein Graft Failure after Coronary Artery Bypass Surgery : Insights from PREVENT IV Running title : (2014) (0)
- The multiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events? (2020) (0)
- Abstract P117: Longer Hospital Length of Stay in Non-ST-Elevation Myocardial Infarction Associated With Higher Risk but Less Evidenced-Based Treatment: Results From ACTION Registry (2011) (0)
- Associated Factors and Clinical Outcomes in Mechanical Circulatory Support use in Patients Undergoing High Risk On-Pump Cardiac Surgery: Insights from the LEVO-CTS trial. (2022) (0)
- Dropping P2Y12 inhibitors in patients with AF undergoing PCI? Not yet a SAFE bet. (2020) (0)
- New onset atrial fibrillation following myocardial infarction is a strong independent predictor of mortality in patients treated with primary percutaneous coronary intervention (2008) (0)
- P4752Apixaban 2.5 mg twice daily is effective and safe for patients with atrial fibrillation and combinations of advanced age, low body weight, and elevated creatinine: insights from ARISTOTLE (2019) (0)
- Antithrombotic Therapy in Patients with ACS and Atrial Fibrillation: A Challenge in Clinical Practice (2011) (0)
- Hidroxicloroquina para Pacientes com COVID-19 não Hospitalizados: Uma Revisão Sistemática e Metanálise de Ensaios Clínicos Randomizados (2023) (0)
- Homocisteína, fator von Willebrand e lipídeos em ratos albinos portadores de diabetes melito induzido por estreptozotocina (2006) (0)
- Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION (2022) (0)
- Abstract 14160: Preservation Solutions, Patency, and Outcomes After Coronary Bypass Surgery (2013) (0)
- P3613Clinical outcomes in patients with atrial fibrillation and echocardiographic risk factors for stroke anticoagulated with apixaban or warfarin (2017) (0)
- Reply (2018) (0)
- AC Forum no Brasil (2016) (0)
- Antivirais para pacientes adultos hospitalizados com infecção por SARS-CoV-2: Um estudo de Fase II/III, randomizado, multicêntrico, controlado por placebo, adaptativo, commúltiplosbraçoseestágios. COALITION COVID-19 BRAZIL IX – REVOLUTIOn: protocolo e plano de análise estatística (2022) (0)
- Justificativa e Desenho do Ensaio Clínico Randomizado COVID-19 Outpatient Prevention Evaluation (COPE - Coalition V): Hidroxicloroquina vs. Placebo em Pacientes Não Hospitalizados (2022) (0)
- THE EFFECT OF PLATELET INHIBITON BY CANGRELOR AMONG OBESE PATIENTS UNDERGOING CORONARY STENTING: INSIGHTS FROM THE CHAMPION TRIALS (2019) (0)
- Hiporresponsividade à terapia antiplaquetária (2009) (0)
- MULTICENTRIC ANALYSIS OF CLINICAL PRESENTATION OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: THE ROAD REGISTRY (2020) (0)
- PROURGEM: Programa de Atualização em Medicina de Urgência e Emergência: Ciclo 15: Volume 1 (2021) (0)
- Avaliação do Seguimento de 1 Ano dos Pacientes Incluídos no Registro da Prática Clínica em Pacientes de Alto Risco Cardiovascular (REACT) (2020) (0)
- Rivaroxabana em Pacientes Ambulatoriais com COVID-19 Leve ou Moderada: Fundamentação e Desenho do Estudo CARE (CARE – Coalition COVID-19 Brazil VIII) (2023) (0)
- Response to Commentary by Giuseppe Mancia (2019) (0)
- Manejo da terapia antitrombótica em pacientes com acidentes vascular cerebral: onde estamos em 2018? (2018) (0)
- Escores de risco de tromboembolismo e sangramento em pacientes com fibrilação atrial (2017) (0)
- BMS-Pfizer Alliance to Unveil Real-World Data Analyses-Cost, Safety and Comparative Effectiveness Findings Associated with Oral Anticoagulants in Non-Valvular Atrial Fibrillation (2018) (0)
- Desfechos clínicos e características da mecânica pulmonar entre a síndrome do desconforto respiratório agudo associada à COVID-19 e a não associada à COVID-19: uma análise de escore de propensão de dois importantes ensaios randomizados (2022) (0)
- Arritmias cardíacas na sala de emergência e UTI. Anticoagulação do paciente com FA aguda submetido a cardioversão: já podemos contar com os novos anticoagulantes orais? (2018) (0)
- Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke (2022) (0)
- Abstract 15347: Symptom Status and Treatment Strategy in Contemporary Management of Atrial Fibrillation: Findings From the ORBIT-AF Registry (2011) (0)
- [Stevens-Johnson syndrome and toxical epidermal necrolysis in intensive care medicine]. (2006) (0)
- Figure 18, Forest plot of maintenance of sinus rhythm for PVI at the time of cardiac surgery versus cardiac surgery alone or in combination with antiarrhythmic drugs or catheter ablation (2013) (0)
- Table 21, Strength of evidence domains for pharmacological rhythm-control therapies (2013) (0)
- Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease (2023) (0)
- Figure 4, Overview of treatment comparisons evaluated for KQ 1 (2013) (0)
- Guimarães, P. O. et al. (2017) Effect of Apixaban on all-cause death in patients with atrial fibrillation: a meta-analysis based on imputed placebo (2018) (0)
- Outcomes following revascularization with radial artery bypass grafts: Insights from the PREVENT-IV trial. (2020) (0)
- Table 14, Strength of evidence domains for antiarrhythmic drugs versus electrical cardioversion (2013) (0)
- EFFECT OF APIXABAN VERSUS VITAMIN K ANTAGONIST AND ASPIRIN VERSUS PLACEBO ON DAYS ALIVE AND OUT OF HOSPITAL IN THE AUGUSTUS RANDOMIZED CONTROLLED TRIAL (2021) (0)
- Low levels of HDL-cholesterol and carotid artery disease: Protocol for systematic review and meta-analysis (2018) (0)
- PLASMA AND TISSUE METABOLOMIC PROFILING IN A PORCINE ISCHEMIA-REPERFUSION MODEL REVEALS NOVEL EARLY MARKERS OF MYOCARDIAL INJURY (2010) (0)
- Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin : results from the ARISTOTLE trial (2016) (0)
- Table 9, Strength of evidence domains for one rate-control procedure versus another (2013) (0)
- How Did We Get Here? Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement: A Review (2022) (0)
- Figure 16, Forest plot of all-cause mortality for Maze procedure versus standard of care (mitral valve surgery) (2013) (0)
- MYOCARDIAL INFARCTION RATES BY DEFINITION, TYPE, AND TREATMENT IN THE ISCHEMIA-CKD TRIAL (2021) (0)
- LONG-TERM SAFETY OF ANTITHROMBOTIC THERAPY IN NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH ATRIAL FIBRILLATION (2011) (0)
- Highlights from American Heart Association, November 4-7, 2007, Orlando, Florida, USA. Late-breaking trials summary. (2008) (0)
- Responding to the letter to the editor by Saver. (2013) (0)
- Abstract 6049: Patients with Thrombocytopenia following Heparin Therapy Have Early but not Late Risk of Death: Results from the CATCH Registry (2008) (0)
- Figure 12, Forest plot of maintenance of sinus rhythm for PVI versus drug therapy (2013) (0)
- Causes of death in patients with atrial fibrillation and a recent acute coronary syndrome or percutaneous coronary intervention: insights from the AUGUSTUS trial (2022) (0)
- Figure 19, Forest plot of maintenance of sinus rhythm for rate- versus rhythm-control strategies (2013) (0)
- Abstract 83: Cardiac Arrest and Cardiopulmonary Resuscitation Knowledge at an Academic Research Organization in Durham, North Carolina (2012) (0)
- Paradoxical Embolism in a Patient with Aortic Valve Endocarditis: A Case Report (2018) (0)
- IMPACT OF A MULTIFACETED EDUCATIONAL INTERVENTION ON ORAL ANTICOAGULATION (OAC) USE IN ATRIAL FIBRILLATION (AF) PATIENTS ACCORDING TO ASPIRIN USE AT BASELINE: INSIGHTS FROM IMPACT-AF TRIAL (2018) (0)
- Report Addendum (Submitted June 13, 2014) (2013) (0)
- UNDETERMINED CAUSE OF DEATH: A POOLED ANALYSIS OF 9,307 DEATHS ACROSS 9 CARDIOVASCULAR TRIALS (2018) (0)
- Association between acute disease severity and one-year quality of life among post-hospitalisation COVID-19 patients: Coalition VII prospective cohort study (2023) (0)
- Figure 22, Forest plot of cardiovascular hospitalizations for rate- versus rhythm-control strategies (2013) (0)
- Figure D, Overview of procedural treatment comparisons evaluated for KQ 5 (2013) (0)
- Table G, Summary of strength of evidence and effect estimate for KQ 5—pharmacological rhythm-control therapies (2013) (0)
- CLOPIDOGREL IS NOT COMMONLY USED BUT ASSOCIATED WITH LESS RE-HOSPITALIZATION IN PATIENTS WITH PERIOPERATIVE MYOCARDIAL INFARCTION FOLLOWING CABG SURGERY (2017) (0)
- Abstract 15603: Does Repeat Measurement of High Sensitivity Troponin I Improve Prediction of Cardiovascular Events in Atrial Fibrillation? (2014) (0)
- Table 20, Strength of evidence domains for rhythm-control procedures (2013) (0)
- Telemedicine for the treatment of foot ulcers in people with diabetes (2021) (0)
- Abstract 15956: Triple Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and History of Coronary Artery Disease: Insights From the ORBIT-AF Registry (2013) (0)
- Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves (2021) (0)
- Figure 25, Forest plot of mixed embolic events for rate- versus rhythm-control strategies (2013) (0)
- Abstract 13963: Type 2 Myocardial Infarction: Incidence, Risk Factors, and Outcomes Among 41,581 Patients Enrolled in 3 Large Randomized Clinical Trials (2019) (0)
- Table 17, Studies assessing recurrence of AF (2013) (0)
- Renal sympathetic ablation using an irrigated-tip catheter: an attractive option? (2013) (0)
- Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease. Reply. (2022) (0)
- Isolated Double Orifice Mitral Valve - a Rare Finding in an Elderly Man (2015) (0)
- Key to Included Primary and Companion Articles (2013) (0)
- Figure 26, Forest plot of bleeding events for rate- versus rhythm-control strategies (2013) (0)
- Table 15, Studies including comparisons of pharmacological agents (2013) (0)
- Table 6, Strength of evidence domains for strict versus lenient rate-control strategies (2013) (0)
- Highlights from American Heart Association, November 4 to 7, 2007, Orlando, FL (2008) (0)
- Alternatives to Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation: A Look Back at the State of the Field in 2012 (2013) (0)
- Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 – Authors' reply (2021) (0)
- Disease Modifying Therapies for Transthyretin Amyloid Cardiomyopathy (2021) (0)
- Abstract 16493: Variation in Patient Characteristics Does Not Explain Regional Differences in Outcomes: Findings From ARISTOTLE (2017) (0)
- [Perforation of esofagic mucosa for enteric tube: case report]. (2006) (0)
- Abstract 21: Transfer Times and Outcomes in ST-Elevations Myocardial Infarction Patients Undergoing Inter-Hospital Transfer for Primary Percutaneous Coronary Intervention: APEX-AMI Insights (2012) (0)
- Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials). (2022) (0)
- Antithrombotic Regimens in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: Trials Evaluating Patient-Centered Outcomes Needed. (2021) (0)
- Rationale and Design for the Myocardial Ischemia and Transfusion (MINT) Randomized Clinical Trial. (2022) (0)
- Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel (2021) (0)
- Abstract 14185: Heart Failure Occurring at any Time During Hospitalization is Associated with Higher Mortality in Non-ST Elevation-Acute Coronary Syndromes (2011) (0)
- Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy-Reply. (2019) (0)
- The reply. (2013) (0)
- Table 7, Heart rate results (24-hour Holter monitor) (2013) (0)
- Figure 14, Forest plot of maintenance of sinus rhythm for transcatheter PVI with or without CFAE ablation (2013) (0)
- Table A, Summary of strength of evidence (SOE) and effect estimate for KQ 1a (2013) (0)
- Table 5, Ventricular rate achieved (2013) (0)
- 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. (2022) (0)
- TRANSFUSIONS, WITH OR WITHOUT CONCOMITANT BLEEDING, ARE ASSOCIATED WITH HIGH SHORT-TERM MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ORAL ANTICOAGULATION (2019) (0)
- Contents (2020) (0)
- Response to: The paradox of implantable cardioverter-defibrillator: When guidelines play against care improvement. (2021) (0)
- Table 12, Comparisons of antiarrhythmic drugs for restoration of sinus rhythm (2013) (0)
- Novel Markers in Patients with Suspected Acute Coronary Syndromes (2009) (0)
- Use of Apixaban and Warfarin in Patients Undergoing Procedures: Insights from ARISTOTLE (P5.002) (2014) (0)
- Table F, Summary of strength of evidence and effect estimate for KQ 5—procedural rhythm-control therapies (2013) (0)
- Table 18, Studies reporting all-cause mortality as an outcome (2013) (0)
- Abstract 16590: Underuse of Oral Anticoagulation, High Use of Aspirin and Worse Clinical Outcomes in Patients With Type 2 Diabetes and Atrial Fibrillation: Insights From the TECOS Trial (2017) (0)
- Table 4, Strength of evidence domains for rate-control drugs (2013) (0)
- Abstract 16928: Fragmented Care Following Transcatheter Aortic Valve Replacement is Associated With Increased 1-year Mortality and Readmission (2017) (0)
- Renal Denervation for the Treatment of Ventricular Arrhythmias: A Systematic Review and Meta-Analysis (2020) (0)
- Abstract 16157: Single Measurement of GDF-15 Provides Reliable Prognostication of Stroke and Major Bleeding in Atrial Fibrillation (2014) (0)
- International Variation in Readmission After Myocardial Infarction—Reply (2012) (0)
- Table D, Summary of strength of evidence and effect estimate for KQ 3—one rate-control procedure versus another (2013) (0)
- Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20–21, 2011, Salvador, Bahia, Brazil (2012) (0)
- This is a repository copy of Antithrombotic therapy after acute coronary syndrome or PCI (2019) (0)
- Mortality after myocardial infarction: the role of renal function and systolic and diastolic functions of the left ventricle. (2013) (0)
- 6072Risk of stroke in hypertensive patients with atrial fibrillation treated with oral anticoagulants (2019) (0)
- Figure 9, Forest plot for restoration of sinus rhythm for amiodarone versus sotalol (2013) (0)
- Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF. (2023) (0)
- Effect of alirocumab on incidence of atrial fibrillation after acute coronary syndromes: insights from ODYSSEY OUTCOMES (2020) (0)
- 2259Ticagrelor in patients wtih symptomatic peripheral artery disease and prior coronary artery disease (2017) (0)
- TCT-48 Incidence and Outcomes of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized Studies (2021) (0)
- Abstract P208: Functional Status, Rehospitalization, and Mortality Outcomes Among Acute Myocardial Infarction Patients with Prior and New-Onset Atrial Fibrillation (2011) (0)
- Clinical Features and Outcomes of Patients with Type 2 Myocardial Infarction : Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome ( TRACER ) (2017) (0)
- Abstract 10159: Underuse of Evidence-based Therapies for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease: Insights from Clinical Research Networks in the United States (2021) (0)
- The ASCEND-NHQ trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis-dependent chronic kidney disease. (2023) (0)
- Abstract 15523: Biomarkers Predict Cause of Death More Accurately Than Clinical Variables in Patients With Atrial Fibrillation on Oral Anticoagulation - Results From the ARISTOTLE Trial (2016) (0)
- Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial (2022) (0)
- Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience (2022) (0)
- Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitors (2022) (0)
- Abstract 6085: Association of Sustained Ventricular Tachycardia/Fibrillation and the Timing of its Occurrence on Outcomes in Patients Undergoing Primary Percutaneous Coronary Interventions: Insights from the APEX-AMI Trial (2008) (0)
- Relationship between ventricular repolarization parameters and the inducibility of ventricular arrhythmias during electrophysiological study in patients with coronary artery disease. (2022) (0)
- List of Contributors (2019) (0)
- Stroke Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack (2012) (0)
- Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial (2023) (0)
- Hydroxychloroquine for Non-Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. (2023) (0)
- Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial. (2023) (0)
- TCT-158 Treating Periodontal Disease in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial. (2016) (0)
- COVID-19 Thrombotic Complications and Therapeutic Strategies. (2022) (0)
- Incidence and risk of short episodes of atrial fibrillation detected with 14 days of continuous electrocardiographic monitoring (2020) (0)
- EXTRA-CARDIAC VASCULAR DISEASE IS ASSOCIATED WITH WORSE FIVE-YEAR CLINICAL OUTCOMES BUT NOT WITH VEIN GRAFT FAILURE AFTER CORONARY ARTERY BYPASS GRAFT SURGERY: INSIGHTS FROM THE PREVENT-IV TRIAL (2013) (0)
- P4774Older patients with atrial fibrillation and comorbidities are less likely to be treated with oral anticoagulation: insights from a nationwide study (2019) (0)
- INTERNATIONAL COMPARISONS OF HEALTH STATUS OUTCOMES IN PATIENTS UNDERGOING INITIAL INVASIVE VERSUS CONSERVATIVE MANAGEMENT FOR CHRONIC CORONARY DISEASE: INSIGHTS FROM THE ISCHEMIA TRIAL (2023) (0)
- TCT-20 Relative Benefit of Double Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Randomized Earlier Versus Later After Index Coronary Event: Insights From the AUGUSTUS Trial (2022) (0)
- P4453Cardiac troponin T concentrations are lower in women than men with atrial fibrillation but have similar prognostic value regardless of sex - insights from the ARISTOTLE trial (2018) (0)
- Understanding Clinical Research (2013) (0)
- Abstract 15473: The Use of Coronary Artery Bypass Grafts in Non-significant Lesions: Is There Harm to Patients? (2014) (0)
- [Adverse systemic reactions in intensive care medicine after isolated limb perfusion with melphalan and hyperthermia: case report]. (2006) (0)
- Corrigendum to "Effectiveness and Safety of Oral Anticoagulants in Adults with Non-valvular Atrial Fibrillation Patients and Concomitant Coronary/Peripheral Artery Disease" American Journal of Medicine 131:09 (2018): 1074-1085.e4. (2020) (0)
- Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Randomized Trial. (2022) (0)
- Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve. Reply. (2021) (0)
- Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial (2022) (0)
- Abstract 12667: Red or White Thrombus in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Does it Matter? (2011) (0)
- [Polyneuropathy in the critical ill patient: a common diagnosis in intensive care medicine?]. (2006) (0)
- Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention-Reply. (2020) (0)
- VE_VC02 SLOPE IN HEART FAILURE PATIENTS DUE TO CHAGAS DISEASE IS AN INDEPENDENT PREDICTOR OF LONGTERM MORTALITY (2012) (0)
- Abstract 15298: Most Strokes Occur More Than 48 Hours Following Primary Percutaneous Coronary Intervention in STEMI: the Stroke Experience in APEX-AMI Trial (2011) (0)
- In people with atrial fibrillation unsuitable for warfarin, apixaban reduces the risk of stroke compared with aspirin, with no difference in major bleeding (2011) (0)
- Digoxina y mortalidad en pacientes con fibrilación auricular (2018) (0)
- Abstract 13344: Is Cardiac Resynchronization Therapy Use Improving Among Racial/Ethnic Minorities? An Analysis of 107,096 Patients from the NCDR-ICD Registry (2011) (0)
- Efficacy and safety of pharmacological interventions in metabolic syndrome: protocol for systematic review and network meta-analysis (2018) (0)
- Abstract 10426: Worse Clinical Outcomes in Patients with Acute Coronary Syndrome and Prior or New Onset Heart Failure: Insights from 47,474 Patients in a Pooled Analysis of Randomized Clinical Trials (2021) (0)
- Erratum (2014) (0)
- Direct oral anticoagulants versus vitamin K antagonists in the first 3 months after bioprosthetic valve replacement: a systematic review and meta-analysis. (2022) (0)
- USE OF INTERACTING DRUGS DID NOT MODIFY TREATMENT EFFECTS OF APIXABAN VERSUS WARFARIN FOR ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL (2017) (0)
- P4747Impact of different estimates of renal function on cardiovascular mortality and major bleeding in patients with atrial fibrillation on oral anticoagulation (2019) (0)
- Abstract P31: Long-Term Outcomes Among Nonagenarians with Non--ST-Segment Elevation Myocardial Infarction (2011) (0)
- SERIOUS INFECTIONS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PCI ARE RARE, BUT ASSOCIATED WITH HIGHER MORTALITY (2011) (0)
- Response to the Letter to the Editor titled "Atrial fibrillation in patients with acute coronary syndromes". (2014) (0)
- RISK OF EARLY HOSPITAL DISCHARGE AFTER ACUTE CORONARY SYNDROMES: INSIGHTS FROM SECURE-PCI TRIAL AND ACCEPT REGISTRY (2020) (0)
- APIXABAN FOLLOWING ACUTE CORONARY SYNDROMES AMONG PATIENTS WITH PRIOR STROKE: INSIGHTS FROM THE APPRAISE-2 TRIAL (2015) (0)
- Combining High Sensitivity Troponin I and T Measurements Improves Prediction of Long-Term Clinical Outcomes in Patients With Atrial Fibrillation - An Aristotle Substudy (2013) (0)
- Abstract 15471: Risk Factors for Cause-Specific Mortality in Patients Anticoagulated for Atrial Fibrillation: Insights From the ARISTOTLE Trial (2016) (0)
- Disseminated Intravascular Coagulation in Cardiac Surgery (2010) (0)
- Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed. (2018) (0)
- Abstract 10216: Use of Antiarrhythmic Drug Therapy and Clinical Outcomes in Elderly Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease (2013) (0)
- AORTIC STENOSIS, BUT NOT MITRAL OR AORTIC REGURGITATION, IS ASSOCIATED WITH ADVERSE OUTCOMES WITH ATRIAL FIBRILLATION: RESULTS FROM THE ARISTOTLE TRIAL (2017) (0)
- Association of BW with Thromboembolic and Bleeding Outcomes in Phase III Randomized Controlled Trials of Direct Oral Anticoagulants: Systematic Review and Meta-Analysis (2016) (0)
- Abstract 18003: Patients With Good Adherence to Study Medication Have Better Outcomes: Insights From the ARISTOTLE Trial (2017) (0)
- Antiplatelets in patients with atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials (2021) (0)
- NOAC USE IS SAFE AND EFFECTIVE FOR PATIENTS WITH ATRIAL FIBRILLATION AND REDUCED RENAL FUNCTION: RESULTS FROM COMBINE-AF (2022) (0)
- Relationship between diabetes, race, obesity and outcomes in patients with acute coronary syndrome: a pool analysis from randomized trials (2013) (0)
- Abstract 13635: Atorvastatin for the Prevention of Major Vascular Events in Patients Undergoing Non-Cardiac Surgery: The LOAD-Pilot Randomized Clinical Trial (2015) (0)
- Epicardial adipose tissue and peripheral artery disease: protocol for systematic review and meta-analysis (2018) (0)
- Stroke and bleeding outcomes with apixaban versus warfarin in patients with high creatinine, low body weight or high age receiving standard dose apixaban for stroke prevention in atrial fibrillation (2015) (0)
- Abstract 14916: Adverse Event Reporting in >48,000 Participants in Four Acute Coronary Syndrome Trials (2015) (0)
- Electrical cardioversion for supraventricular arrhythmias in octagenarians (2019) (0)
- 726 Acute Phase Inflammatory Biomarkers Add Little Predictive Value to Clinical Factors Plus NT-proBNP Among Patients With ST-Segment Elevation Myocardial Infarction: An Apex AMI Trial Substudy (2012) (0)
- The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. (2021) (0)
- COMPARATIVE EFFECTIVENESS AND SAFETY OF ANTITHROMBOTIC THERAPY IN OLDER PATIENTS WITH ATRIAL FIBRILLATION AND NON-ST ELEVATION MYOCARDIAL INFARCTION (NSTEMI) TREATED WITH CORONARY STENTING (2012) (0)
- [Iatrogenic in intensive care medicine]. (2006) (0)
- Abstract 5764: Discharge Without Antiplatelet Therapy After Inhospital Bleeding is an Independent Predictor of 6-Month Mortality Among Patients With Acute Coronary Syndrome: A Pooled Analysis From PURSUIT, PARAGON-A, PARAGON-B and SYNERGY (2009) (0)
- Abstract 16738: International Variation in Management and Clinical Outcome of Patients With Type 2 Diabetes and Heart Failure: Insights From TECOS (2017) (0)
- Cardiovascular Event Hazards over Time in TECOS (2018) (0)
- Efficacy and Safety of Topical or Oral Hydrolyzed Collagen in Women with Dermatoporosis: A Randomized, Double-Blind, Factorial Design Study (2022) (0)
- Abstract 16954: Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Cardiovascular Prevention Treatments in Patients With Coronary Artery Disease Insights From the Bridge Cardiovascular Prevention Cluster Randomized Trial (2020) (0)
- COMPARISON BETWEEN CENTRAL CLINICAL EVENTS CLASSIFICATION COMMITTEE AND SITE INVESTIGATOR ASSESSMENT OF CLINICAL OUTCOMES: INSIGHTS FROM THE NAVIGATOR TRIAL (2016) (0)
- Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial (2021) (0)
- Therapeutical hypothermia after cardiopulmonary resuscitation: evidences and practical issues. (2009) (0)
- Very low levels of HDL-cholesterol and stroke: Protocol for systematic review and meta-analysis (2018) (0)
- Efficacy and Safety of Ixekizumab vs. Low-Dose IL-2 vs. Colchicine vs. Standard of Care on the Treatment of Patients Hospitalized with Moderate to Critical Covid-19: A Pilot Randomized Clinical Trial (STRUCK: Survival Trial Using Cyto kine Inhibitors) (2022) (0)
- Integrating Electronic Health Records in the Delivery of Optimized Anticoagulation Therapy (2015) (0)
- Abstract 16487: Effectiveness and Safety of Apixaban versus Other Oral Anticoagulants in Older Adults With Non-Valvular Atrial Fibrillation and Concomitant Coronary Artery Disease or Peripheral Arterial Disease (2017) (0)
- Dabigatran Compared With Rivaroxaban vs Warfarin. (2017) (0)
- Safety and efficacy of antithrombotic therapy according to stroke and bleeding risk in patients with atrial fibrillation and acute coronary syndrome or PCI: insights from AUGUSTUS (2020) (0)
- Low levels of HDL-cholesterol and endothelial dysfunction: a systematic review and meta-analysis (2018) (0)
- Abstract 18048: Early Termination of Cardiovascular Clinical Trials Registered in ClinicalTrials.gov: Where Do We Stand? (2013) (0)
- P976Elevated biomarkers are associated with increased risk of death and heart failure hospitalization in patients with atrial fibrillation: insights from the ARISTOTLE trial (2018) (0)
- Abstract 9147: Undiagnosed Diabetes Mellitus, Pre-Diabetes, and Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes (2011) (0)
- Outcomes With Apixaban by Type of Atrial Fibrillation: Results From the Aristotle Trial (2012) (0)
- APIXABAN VERSUS WARFARIN AND ASPIRIN VERSUS PLACEBO ACCORDING TO RENAL FUNCTION AFTER ACUTE CORONARY SYNDROME OR PCI IN ATRIAL FIBRILLATION: INSIGHTS FROM THE AUGUSTUS TRIAL (2020) (0)
- [Quality and humanization of the attendance in Intensive Care Medicine. What the parents think's?]. (2006) (0)
- Abstract 15520: Use of the Novel Biomarker-Based ABC-Bleeding Risk Score Over Time in Atrial Fibrillation: Insights From the ARISTOTLE Trial (2016) (0)
- Anticoagulation dosing in atherosclerotic cardiovascular disease: Is less more? (2020) (0)
- P2685INR prior to bleeding is below 3.0 most of the time in patients with atrial fibrillation using warfarin (2017) (0)
- P2552Triple vs. double antithrombotic therapy in patients needing oral anticoagulation undergoing percutaneous coronary intervention: a meta-analysis (2019) (0)
- Hypertensive emergencies. (2008) (0)
- A RANDOMIZED CLINICAL TRIAL OF SCREENING FOR ATRIAL FIBRILLATION WITH A 14-DAY PATCH MONITOR: ANALYSIS OF ECG RECORDINGS FROM THE GUARD-AF STUDY (2022) (0)
- Efficacy and Safety of Apixaban in Patients With Atrial Fibrillation According to Sex : Results From the ARISTOTLE Trial (2013) (0)
- Reply: To PMID 24360877. (2014) (0)
- Efficacy and safety of cangrelor in patients with peripheral artery disease undergoing percutaneous coronary intervention – Insights from the CHAMPION program (2021) (0)
- Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn trial (2023) (0)
- LOW VO2 PEAK IS INDEPENDENTLY ASSOCIATED WITH IMPROVEMENT IN FUNCTIONAL CAPACITY AFTER CARDIAC REHABILITATION: RESULTS FROM A NATIONAL AND MULTICENTER STUDY (2018) (0)
- WHAT THRESHOLD SHOULD BE USED TO DEFINE PERCUTANEOUS CORONARY INTERVENTION-RELATED MYOCARDIAL INFARCTION? AN APPROACH BASED ON CLINICAL RELEVANCE FROM EARLY ACS AND SYNERGY (2011) (0)
- Statins in patients with peripheral artery disease: A protocol for a systematic review and network meta-analysis (2018) (0)
- TCT-1 Bleeding in Patients With Atrial Fibrillation and Acute Coronary Syndrome or PCI Treated With Antithrombotic Therapy: Insights From the AUGUSTUS Trial (2022) (0)
- Tumor lysis syndrome: a review for the clinician (2013) (0)
- Clinical outcomes after hybrid coronary revascularizationversuscoronaryarterybypasssurgery (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Renato Delascio Lopes?
Renato Delascio Lopes is affiliated with the following schools:
